Abstract
Ventriculoperitoneal shunt infection is a serious clinical problem for which implant removal is considered the treatment of choice. However, surgery is sometimes associated with considerable risks that may outweigh the benefits. Presented here is a case of ventriculoperitoneal shunt infection treated successfully with linezolid without implant removal. This case shows linezolid could be a therapeutic alternative when surgery is contraindicated.
MeSH terms
-
Acetamides / therapeutic use*
-
Anti-Bacterial Agents / therapeutic use*
-
Device Removal
-
Humans
-
Linezolid
-
Male
-
Methicillin Resistance
-
Middle Aged
-
Oxazolidinones / therapeutic use*
-
Staphylococcal Infections / drug therapy*
-
Staphylococcal Infections / etiology*
-
Staphylococcus epidermidis* / drug effects
-
Staphylococcus epidermidis* / isolation & purification
-
Ventriculoperitoneal Shunt / adverse effects*
Substances
-
Acetamides
-
Anti-Bacterial Agents
-
Oxazolidinones
-
Linezolid